Welcome to LookChem.com Sign In|Join Free
  • or
6,7-dimethoxy-1-(3,4,5-trimethoxyphenyl)isoquinoline is a complex organic compound belonging to the isoquinoline family. It is characterized by a tricyclic structure, with two methoxy groups at the 6 and 7 positions and a phenyl ring substituted with three methoxy groups at the 3, 4, and 5 positions, attached to the isoquinoline core. 6,7-dimethoxy-1-(3,4,5-trimethoxyphenyl)isoquinoline is known for its potential pharmacological properties and is often studied for its interactions with various biological targets. Its chemical structure contributes to its unique reactivity and stability, making it a subject of interest in medicinal chemistry and drug development.

3161-13-5

Post Buying Request

3161-13-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3161-13-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3161-13-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,6 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3161-13:
(6*3)+(5*1)+(4*6)+(3*1)+(2*1)+(1*3)=55
55 % 10 = 5
So 3161-13-5 is a valid CAS Registry Number.

3161-13-5Downstream Products

3161-13-5Relevant academic research and scientific papers

Cerium Chloride Catalyzed, 2-Iodoxybenzoic Acid Mediated Oxidative Dehydrogenation of Multiple Heterocycles at Room Temperature

Hati, Santanu,Sen, Subhabrata

, p. 1277 - 1280 (2017)

Catalytic cerium chloride was found to activate 2-iodoxybenzoic acid (IBX) for the oxidative dehydrogenation of tetrahydroisoquinolines, tetrahydro-β-carbolines, and thiazolidines to their dehydrogenated and aromatic forms at room temperature in moderate to excellent yields. The robustness of the protocol was demonstrated by scaling up the reactions to multigram quantities.

Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors

Kraus, Yvonne,Glas, Carina,Melzer, Benedikt,Gao, Li,Heise, Constanze,Preu?e, Monique,Ahlfeld, Julia,Bracher, Franz,Thorn-Seshold, Oliver

, (2020)

We here report the discovery of isoquinoline-based biaryls as a new scaffold for colchicine domain tubulin inhibitors. Colchicinoid inhibitors offer highly desirable cytotoxic and vascular disrupting bioactivities, but their further development requires improving in vivo robustness and tolerability: properties that both depend on the scaffold structure employed. We have developed isoquinoline-based biaryls as a novel scaffold for high-potency tubulin inhibitors, with excellent robustness, druglikeness, and facile late-stage structural diversification, accessible through a tolerant synthetic route. We confirmed their bioactivity mechanism in vitro, developed soluble prodrugs, and established safe in vivo dosing in mice. By addressing several problems facing the current families of inhibitors, we expect that this new scaffold will find a range of in vivo applications towards translational use in cancer therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3161-13-5